LFWD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lifeward Ltd (LFWD) is not a strong buy at this time for a beginner investor with a long-term strategy. While the company has shown some positive developments, such as regaining Nasdaq compliance and slight improvements in revenue and net income, the financials remain weak with negative EPS and net income. Additionally, there are no significant trading signals or strong technical indicators suggesting immediate upside potential. A hold strategy is recommended until further positive financial or technical developments occur.
The MACD is positive and expanding, suggesting a bullish trend. However, the RSI is neutral at 61.443, and moving averages are converging, indicating no strong directional momentum. Key resistance is at 7.188, and support is at 5.416, with the stock currently trading near its pivot point of 6.302.
Lifeward has regained Nasdaq compliance, eliminating delisting risks. The company is committed to innovative medical solutions and operates globally, which could support long-term growth.
and net income (-3,170,000), indicating ongoing financial struggles. There are no significant hedge fund or insider trading trends, and no recent congress trading data.
In Q3 2025, revenue increased by 1.09% YoY to 6,195,000, and net income improved by 2.79% YoY but remains negative at -3,170,000. EPS dropped significantly by -43.97% YoY to -2.37, while gross margin improved by 20.62% YoY to 43.7%.
No analyst rating or price target data provided for evaluation.
